Filing Details
- Accession Number:
- 0001735276-25-000004
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-01-29 16:03:42
- Reporting Period:
- 2025-01-27
- Accepted Time:
- 2025-01-29 16:03:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1178670 | Alnylam Pharmaceuticals Inc. | ALNY | Pharmaceutical Preparations (2834) | 770602661 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1829252 | Pushkal Garg | 675 West Kendall Street Henri A. Termeer Square Cambridge MA 02142 | Cmo & Evp Dev & Med Affairs | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-01-27 | 23,876 | $88.95 | 39,581 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2025-01-27 | 25,000 | $88.95 | 64,581 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-01-27 | 52,592 | $285.00 | 11,989 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Performance Stock Option 2015 (right to buy) | Disposition | 2025-01-27 | 25,000 | $0.00 | 25,000 | $88.95 |
| Common Stock | Stock Option (right to buy) | Disposition | 2025-01-27 | 23,876 | $0.00 | 23,876 | $88.95 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2019-08-06 | 2025-12-18 | No | 4 | M | Direct |
| 0 | 2019-12-18 | 2025-12-18 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 431 | Indirect | by Managed Account |
| Common Stock | 250 | Indirect | by Trust |
Footnotes
- All transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on September 11, 2024. The 48,876 options exercised and sold by the reporting person were due to expire on December 18, 2025.
- Reflects shares of ALNY common stock acquired by the Reporting Person under the issuer 401(k) plan as a result of the issuer 401(k) matching contribution program.
- Represents shares held in trust, of which the Reporting Persons spouse is co-trustee. The Reporting Person disclaims beneficial ownership of these shares, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- This stock option was fully vested and exercisable as of August 6, 2019.
- This stock option was fully vested and exercisable as of December 18, 2019.
Billionaire Hedge Funds
